Use of drug-eluting stents in Brazil: The CENIC (National Registry of Cardiovascular Interventions) Registry;Perfil de uso dos stents farmacológicos no Brasil: Dados da Central Nacional de Intervenções Cardiovasculares (CENIC)

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 6, 2007, Pages

  Cardoso, Cristiano O ^a   De Quadros, Alexandre Schaan ^a   Mattos, Luiz A ^a   Gottschall, Carlos A ^a   Sarmento Leite, Rogério E ^a   Marin Neto, José A ^a  

^a Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista ^*  (Brazil)

Author keywords

Coronary arteriosclerosis; Coronary restenosis; Drug eluting stents; Stents

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOGRAPHY; ARTICLE; BRAZIL; CHI SQUARE TEST; COMPARATIVE STUDY; DRUG ELUTING STENT; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; TREATMENT OUTCOME; CHI SQUARE DISTRIBUTION; CHILD; HEART MUSCLE ISCHEMIA; MIDDLE AGED; REGISTER; TIME; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAZIL; CHI-SQUARE DISTRIBUTION; CHILD; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 41149137142     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2007001800002     Document Type: Article

References (24)

1. Kastrati A, Dibra A, Eberle S, Mehilli J, Suarez de Lezo J, Goy JJ, et al. Sirolimuseluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005; 294 (7): 819-25.
2. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005; 353 (7): 663-70.
3. Jimenez-Quevedo P, Sabate M, Angiolillo DJ, Costa MA, Alfonso F, Gomez-Hospital JA, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. J Am Coll Cardiol. 2006; 47 (11): 2172-9.
4. Peixoto DS, Tanajura LF, Sousa AG, Centemero MP, Chaves AJ, Maia JP, et al. Unstable angina patients treated with percutaneous coronary intervention in the new millennium: what characterizes them? Arq Bras Cardiol. 2007; 88 (1): 26-30.
5. Gogo PB Jr, Dauerman HL, Mulgund J, Ohman EM, Patel MR, Cohen DJ, et al. Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). Am J Cardiol. 2007; 99 (9): 1222-6.
6. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000; 284 (7): 835-42.
7. Mattos LA, Sousa AG, Campos Neto CM, Labrunie A, Alves CR, Feres F, et al. The use of primary stenting or balloon percutaneous transluminal coronary angioplasty for the treatment of acutely occluded saphenous vein grafts: results from the Brazilian National Registry-CENIC. Central Nacional de Intervenções Cardiovasculares. Arq Bras Cardiol. 2001; 76 (6): 483-95.
8. Mattos LA, Sousa AG, Neto CC, Labrunie A, Alves CR, Saad J. Primary coronary angioplasty and stent implantation in acute myocardial infarction: comparative analysis of the in-hospital results in the CENIC/SBHCI registry. National Center of Cardiovascular Interventions members. Arq Bras Cardiol. 1999; 73 (6): 475-84.
9. Mattos LA, Sousa AG, Pinto IM, Silva ER, Carneiro JK, Sousa JE, et al. A comparison of rescue and primary percutaneous coronary interventions for acute myocardial infarction: a multicenter registry report of 9,371 patients. Arq Bras Cardiol. 2004; 82 (5): 440-4.
10. Moscoso I, Garcia LC, Dourado GO, Mauro MF, Caramori P, Coelho W, et al. Influence of Diabetes Mellitus on immediate results of coronary stent: National Center for Cardiovascular Interventions (CENIC) data analysis. Arq Bras Cardiol. 2006; 86 (3): 181-90.
11. Mangione J. Percutaneous coronary intervention in Brazil: what are the figures? Rev Bras Cardiol Invas. 2006; 14 (3): 267-72.
12. Sousa AG. Percutaneous cardiovascular intervention procedures in Brazil (1992-1993). Report of the National Registry-National Center for Cardiovascular Interventions. Arq Bras Cardiol. 1994; 62 (4): 217-23.
13. Steinberg DH, Mishra S, Javaid A, Slottow TL, Buch AN, Roy P, et al. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol. 2007; 99 (5): 599-602.
14. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007; 297 (18): 1992-2000.
15. Ligthart S, Vlemmix F, Dendukuri N, Brophy JM. The cost-effectiveness of drug-eluting stents: a systematic review. CMAJ. 2007; 176 (2): 199-205.
16. Russell S, Antonanzas F, Mainar V. Economic impact of the taxus coronary stent: implications for the Spanish healthcare system. Rev Esp Cardiol. 2006; 59 (9): 889-96.
17. Polanczyk C, Wainstein M, Ribeiro J. Cost-effectiveness of sirolimus-eluting stents in percutaneous coronary interventions in Brazil. Arq Bras Cardiol. 2007; 88 (4): 464-74.
18. Araújo D, Lima V, Ferraz M. Impact analysis of drug-eluting stent in the unified health system budget. Arq Bras Cardiol. 2007; 88 (4): 458-63.
19. Quadros A, Gottschall C, Sarmento-leite R. Cost-effectiveness of drug-eluting stents in large vessel. Rev Bras Cardiol Invas. 2006; 14 (3): 306-13.
20. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004; 109 (2): 190-5.
21. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005; 294 (10): 1215-23.
22. Saia F, Piovaccari G, Manari A, Santarelli A, Benassi A, Aurier E, et al. Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry. J Am Coll Cardiol. 2006; 48 (7): 1312-8.
23. Wu C, Hannan EL, Walford G, Ambrose JA, Holmes DR Jr, King 3rd SB, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006; 47 (3): 654-60.
24. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J. 2006; 27 (23): 2784-814.